Kezar Life Sciences, Inc.·4

Jul 1, 5:25 PM ET

To Zung Phuong 4

4 · Kezar Life Sciences, Inc. · Filed Jul 1, 2025

Insider Transaction Report

Form 4
Period: 2025-07-01
To Zung Phuong
Chief Development Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-07-01+7,0007,000 total
    Exercise: $4.40Exp: 2035-06-30Common Stock (7,000 underlying)
Footnotes (1)
  • [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on July 1, 2025, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file
  • 4
    form4-07012025_090724.xmlPrimary